Form 4 for ABT Abbott Laboratories
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-13 · accession 0001415889-22-012600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-15 | 2022-12-13 | ABT | Ginascol John F | EVP | S - Sale | $112.32 | -11.0K | 111.9K | -9% | -$1.24M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-12-13 | S | D | 11,000 | $112.32 | 111,912 | D | — | — |